「大麻グミ」などに含まれる薬物の代謝物を解明~科学捜査や救命救急での摂取証明に期待~

ad

2025-08-26 理化学研究所

理化学研究所の研究チームは、「大麻グミ」「大麻リキッド」などに含まれる規制薬物とその類縁体18種類について、ヒト肝臓由来酵素を用いた試験管内実験で主要な代謝物を特定しました。解析の結果、各薬物は6~16種類の代謝物に変化し、化学構造の違い(R/S体や側鎖長)に応じた特徴的な代謝パターンを示すことが明らかになりました。さらに、実際の使用者の尿サンプルから、薬物本体は検出されなかったものの、実験で確認された代謝物3種類を同定。これにより、尿検査で代謝物を指標とすることで摂取証明が可能になることが示されました。本研究は新たな危険ドラッグの登場にも対応可能な代謝物予測につながり、科学捜査や救命救急での証拠検出や迅速な対応に貢献することが期待されます。成果は『Clinical Chemistry』誌に掲載されました。

「大麻グミ」などに含まれる薬物の代謝物を解明~科学捜査や救命救急での摂取証明に期待~
危険ドラッグの代謝物分析の流れ

<関連情報>

18種類の半合成カンナビノイド(ヘキサヒドロカンナビノール(HHC)とその類似体)のin vitro代謝プロファイリングと、真正ヘキサヒドロカンナビホロール(HHCP)尿サンプルでの同定 In Vitro Metabolic Profiling of 18 Semi-Synthetic Cannabinoids—Hexahydrocannabinol (HHC) and Its Analogs—with Identification in an Authentic Hexahydrocannabiphorol (HHCP) Urine Sample

Shimpei Watanabe , Takaya Murakami , Seiji Muratsu , Saito Takeshi , Yasuo Seto
Clinical Chemistry  Published:25 August 2025
DOI:https://doi.org/10.1093/clinchem/hvaf087

Abstract

Background

Hexahydrocannabinol (HHC) and its analogs are recent additions to semi-synthetic cannabinoids in the recreational drug market. Here, the metabolism of 18 HHC analogs was compared to gain a comprehensive understanding of the structure–metabolism relationship of HHC analogs and to identify urinary biomarkers. Additionally, an authentic urine sample obtained from a suspected hexahydrocannabiphorol (HHCP) user was analyzed.

Methods

Both 9(R)- and 9(S)-epimers of HHC and 8 analogs were separately incubated with human liver microsomes (HLMs) for 1 h. The resulting products and the urine sample were analyzed by liquid chromatography–high-resolution mass spectrometry in an untargeted approach.

Results

The metabolites were generated by hydroxylation, dehydrogenation, ketone formation, carboxylation, or hydrolysis, either alone or in combination. Concerning the HHC homologs, for 9(R)-epimers, metabolites with multiple biotransformations, e.g., dihydroxy metabolites, were generally more abundant, and the percentage of hydroxy metabolites tended to increase for the longer side-chain homologs, while the reverse was observed for dihydroxy metabolites. For 9(S)-epimers, a metabolite hydroxylated at the methylcyclohexyl moiety was by far the most abundant metabolite, with similar behaviors among hexahydrocannabivarin, hexahydrocannabutol, and HHC, and between hexahydrocannabihexol and HHCP. Acetylated analogs initially underwent hydrolysis to produce almost identical metabolic profiles as the non-acetylated analogs. Methyl ether analogs did not appear to show any particular metabolic trend. In the clinical urine sample, 3 HHCP (di-)hydroxylated metabolites were detected, matching the HLM results.

Conclusions

The revealed structure–metabolism relationship could serve as a reference for investigating the metabolism of similar cannabinoids, while the identified biomarkers could facilitate drug testing.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました